Directors and Officers
Herbert Moessler, Ph.D.
Chairman of the Board of Directors
Dr. Moessler is one of the founding members of Neuropore Therapies Inc. He currently serves as the Chairman of the Board of Director for Neuropore Therapies, Inc. and as an advisor for the EVER Pharma Group in Austria.
Dr. Moessler has extensive experience with all aspects of international pharma business and has devoted his professional career to the development, marketing and sales of therapeutic agents and health products for neurological disorders.
Prior to his current assignments, he held the positions of CEO of Neuropore Therapies, CEO of EVER Neuro Pharma, Austria and Staff Scientist at the Institute of Molecular Biology of the Austrian Academy of Sciences.
He received his PhD in Molecular Biology and Genetics from the University of Salzburg, Austria, and his MBA from the Danube University in Krems, Austria.
Hans Meier-Scherling, MBA
Mr. Meier-Scherling currently serves as managing partner of the advisory firm Quirinus Capital GmbH focused on corporate finance and M&A services for clients in the healthcare industry. He has extensive experience with international capital markets and M&A transaction with clients from industry and private equity.
Prior to forming Quirinus Capital, Mr. Meier-Scherling held the positions of Managing Director of Credit Suisse, Managing Director of Rothschild, Executive Director and Vice President at Morgan Stanley, and Vice President at JP Morgan.
He received his BA in Business Administration from University of Applied Sciences Rhineland, and his MBA from Harvard Business School.